losartan-potassium and Lung-Diseases--Interstitial

losartan-potassium has been researched along with Lung-Diseases--Interstitial* in 1 studies

Other Studies

1 other study(ies) available for losartan-potassium and Lung-Diseases--Interstitial

ArticleYear
Erythrocytosis in a scleroderma patient.
    The Mount Sinai journal of medicine, New York, 2006, Volume: 73, Issue:3

    A 40-year-old black male with scleroderma lung disease presented with blurry vision and headache. His presenting hemoglobin was 22.3 g/dL and his serum erythropoietin level was surprisingly low. Although nocturnal hypoxemia was evident, his daytime resting arterial oxygen saturation was normal. The patient's symptoms of hyperviscosity improved after phlebotomy, as his hemoglobin gradually decreased to 18.3 g/dL. Repeat serum erythropoietin levels were in normal and high ranges. Patients with chronic interstitial lung disease and erythrocytosis could have normoxemia at rest and a normal or low serum erythropoietin level at the peak of erythrocytosis. A repeat sampling of serum erythropoietin and monitoring of oxygen saturation during sleep and exertion may help in diagnosis. Physicians should prescribe continuous oxygen therapy for patients with chronic interstitial lung disease and erythrocytosis, even if diurnal resting hypoxemia is absent.

    Topics: Adult; Chronic Disease; Erythropoietin; Headache; Humans; Lung Diseases, Interstitial; Male; Oxygen Inhalation Therapy; Polycythemia; Scleroderma, Systemic; Vision, Low

2006